Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 600,805,500
  • Shares Outstanding, K 9,150
  • 60-Month Beta 0.70
  • Price/Earnings ttm 16.55
  • Annual Dividend & Yield 1.14 (1.73%)
  • Most Recent Dividend 0.211 on 12/17/24
  • Management Fee 0.39%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 11.69% ( -7.97%)
  • Historical Volatility 12.21%
  • IV Percentile 39%
  • IV Rank 41.63%
  • IV High 27.19% on 11/18/24
  • IV Low 0.64% on 10/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 110
  • Open Int (30-Day) 131

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.99 +0.91%
on 12/19/24
69.47 -5.60%
on 12/04/24
-2.81 (-4.11%)
since 11/22/24
3-Month
64.99 +0.91%
on 12/19/24
71.96 -8.87%
on 10/17/24
-5.78 (-8.10%)
since 09/23/24
52-Week
60.88 +7.73%
on 12/26/23
72.94 -10.09%
on 09/03/24
+4.60 (+7.55%)
since 12/22/23

Most Recent Stories

More News
Eli Lilly Stock: Is Wall Street Bullish or Bearish?

Eli Lilly has outperformed the broader market and its peers this year, and Wall Street analysts are bullish about the stock’s prospects.

$SPX : 5,917.04 (-0.23%)
IHE : 65.84 (+0.20%)
LLY : 783.50 (+2.05%)
Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

$SPX : 5,917.04 (-0.23%)
JNJ : 143.77 (-0.48%)
IHE : 65.84 (+0.20%)
Bristol-Myers Stock: Is Wall Street Bullish or Bearish?

Bristol-Myers has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

$SPX : 5,917.04 (-0.23%)
IHE : 65.84 (+0.20%)
BMY : 56.83 (-0.87%)
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 64.66 (-1.33%)
BE : 23.35 (-3.19%)
CVX : 142.02 (-0.58%)
JPM : 235.17 (-1.02%)
MRK : 98.26 (+0.21%)
IHE : 65.84 (+0.20%)
PPH : 86.77 (+0.27%)
UNH : 503.12 (+0.60%)
PFE : 26.33 (-0.11%)
KBH : 65.30 (-0.85%)
XLE : 82.99 (-1.37%)
XHB : 104.82 (-1.10%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 137.21 (-0.57%)
JNJ : 143.77 (-0.48%)
IHE : 65.84 (+0.20%)
IYH : 58.21 (-0.15%)
PPH : 86.77 (+0.27%)
FTXH : 26.98 (+0.88%)
How Is Eli Lilly’s Stock Performance Compared to Other Drug Manufacturer Stocks?

Eli Lilly has recently outperformed the general drug manufacturers industry, and analysts are highly optimistic about the stock’s prospects.

LLY : 783.50 (+2.05%)
IHE : 65.84 (+0.20%)
JNJ : 143.77 (-0.48%)
Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly has significantly outperformed the broader market over the past year, and Wall Street analysts are bullish about the stock’s prospects.

LLY : 783.50 (+2.05%)
$SPX : 5,917.04 (-0.23%)
IHE : 65.84 (+0.20%)
Merck & Co. Stock: Analyst Estimates & Ratings

Despite Merck & Co.’s relative underperformance over the past year, Wall Street analysts remain bullish about the stock’s prospects.

MRK : 98.26 (+0.21%)
$SPX : 5,917.04 (-0.23%)
IHE : 65.84 (+0.20%)
Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

JNJ : 143.77 (-0.48%)
$SPX : 5,917.04 (-0.23%)
IHE : 65.84 (+0.20%)
Is Wall Street Bullish or Bearish on Viatris' Stock?

Viatris has underperformed the broader market over the past year, and Wall Street analysts are cautious about the stock’s prospects.

VTRS : 12.40 (-0.96%)
$SPX : 5,917.04 (-0.23%)
IHE : 65.84 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 67.16
2nd Resistance Point 66.81
1st Resistance Point 66.26
Last Price 65.84
1st Support Level 65.37
2nd Support Level 65.03
3rd Support Level 64.48

See More

52-Week High 72.94
Fibonacci 61.8% 68.33
Fibonacci 50% 66.91
Last Price 65.84
Fibonacci 38.2% 65.48
52-Week Low 60.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar